Esketamine (intranasal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Esketamine (intranasal), covering 2022-05-24 to 2022-05-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression [Phase 3]